Curiously, IGPR-1 is strongly phosphorylated by doxorubicin and regulates sensitivity of tumor cells to doxorubicin (17), indicating that IGPR-1 through induction of autophagy program could contribute to the development of resistance in cancer cells. This evidence concerns the gene TMIGD2 and cancer.